ATLANTHERA is a startup based in France, most recent round Seed, 3 tracked investors.
Based in France, ATLANTHERA is a startup. Its most recent tracked round is Seed. Brouky records 3 investors associated with the company.
Atlanthera is a biotechnology company that develops new treatments for bone and joint diseases such as osteosarcoma, bone metastases, arthritis, and osteomyelitis. The company uses innovative drug delivery systems to target active ingredients directly to bone and joint tissues, reducing systemic adverse effects.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.